Japan approves Sanofi’s Sarclisa combo for MM treatment

​Sanofi has received approval from Japan's Ministry of Health, Labour and Welfare for its SC formulation of Sarclisa in combination with standard therapies to treat multiple myeloma.

The post Japan approves Sanofi’s Sarclisa combo for MM treatment appeared first on Hospital Management.

 

Back to the Featured Stories

Featured Stories

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism
Charles River collaborates with Lilly TuneLab platform
MAIA activates new site for THIO-101 Phase II trial
Biogen to acquire RayThera for up to $1bn
Global semiconductors hiring slows after Q1 surge: What this means for your sector

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.

Contact Us